Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by saveyourselfnowon Aug 08, 2018 8:48pm
165 Views
Post# 28430962

RE:PART 2 - a letter to shortters and ACB longs....

RE:PART 2 - a letter to shortters and ACB longs....
Nathan2018 wrote: Thank you so much for all your wonderful replies. 

There were some re..tards in here that said some re..tard things. 

1. I am a pumper?  go read my very first post here. There i said, i am not a shortter....i also said i HATE THE ACB LOVERS....who say...the stock is going to go up to 10$ by friday or VERY OPTIMISTIC PEOPLE HERE....

I said i am a realistic player...meaning....i dont love the stock when it goes down or up...if it goes up..it better have a good reason....if it goes down...it better have good reason....

otherwise i become suspicious.....

2. i also sent a letter to ACB and this is what the reply is:  i asked several questions...all answers are meshed together. 


I’ll do my best to answer all of your questions below. I appreciate the concern and frustration with respect to the recent share price performance. While it is true we have entered into a lot of transactions, this has enabled us to build a vertically integrated, horizontally diversified company that, we believe, will be exceptionally well positioned to capture margin along the cannabis industry value chain.
 
MedReleaf adds scale, efficiencies, product diversification, a strong medical and strong adult consumer use brands, additional international exposure, expanded domestic distribution, and further strategic synergies. Anandia adds incredible capabilities at the research end, which, among others, will enable us to develop new strains for particular applications or strains that are optimized for automated cultivations (let's assume that this will allow us to either increase yields or reduce costs by a few % points. On the scale of Sky, Nordic and Sun, that would have a dramatically positive impact). Our other investments have added tremendous value too.
 
For instance, look at our investment in TGOD, in which we own approximately 40 million shares at an average cost price of C$1.84, and which currently trade at C$5.65, a gain of over C$150 million, and we hold warrants too that are in the money. Similar for investments in companies such as Hempco, Cann Group, Choom and Radient. We are building a company that we believe will be able to capture share of the international cannabis opportunity, and doing this with large-scale, highly efficient, low cost production of high quality cannabis and high value added products.
 
With respect to the TFSA question – the spin off would not count as a voluntary contribution to your TFSA, rather it would be treated as a gain on investment. So regardless of the amount of money you’ve deposited this year (you can allocated up to $5,500K per year into your TFSA in 2018), this would be treated separated. More details on the annual contribution limits can be found here:https://www.macleans.ca/economy/money-economy/tfsa-contribution-limit/.
 
At this time, the company has not indicated that it would pursue a reverse stock split.
 
Edible products are not currently legalized, the expectation is that the federal government will table legislation to legalize edibles in 2019.
 
Insider transactions are tracked on SEDI (www.sedi.ca).
 
Shorting of stocks is a legal practice in Canada, an issuer can not do anything to stop someone from doing so.
 
Kind regards,
 
Robert Kelly Director of Investor Relations


 
Phone: +1 (647) 331-7228
Email: rob.kelly@auroramj.com 
Stock: TSX:ACB | OTCQX:ACBFF
Auroramj.com
 
 
 



looks to me like you got your answers Nathan

if I were an ACB shareholder I would thank you for your hard work and unconventional methods of obtaining encouraging news for shareholders

I would hire you in some capacity if I wanted answers to an issue but did not have the time nor focus to seek those answers myself

you started a project, ran into some difficulty and then mastered the course

keep up the good work


Bullboard Posts